Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lithos Group Ltd N.LITS

Alternate Symbol(s):  LITSF

Lithos Group Ltd., formerly Lithos Energy Ltd., is engaged in delivering sustainable lithium. The Company offers AcQUA, which is a patent-pending technology that spans the complete value chain from the conditioning and pre-treatment of raw brines through the direct lithium extraction (DLE) phase into the polishing and purification of battery grade lithium feedstock. The Company has two processing facilities: a 4,000 square feet (sq ft) lab in Denver, Colorado and a 55,000 sq ft complex in Bessemer, Alabama. The Company is engaged in a contract with multiple strategic mineral resource owners and processing brines from the Salars in Chile and Argentina, and the Smackover reservoir in the Southeastern United States. The Company’s wholly owned subsidiary is Aqueous Resources LLC.


NEO:LITS - Post by User

Bullboard Posts
Post by Vozadayon Mar 19, 2018 11:30am
82 Views
Post# 27739570

Question and speculation

Question and speculationOk, so on the website it says they are planning on buying the new facility and having it ACMPR approved.  My question is, could BC Genetics have applied for a license without AMS having to announce it since they do not own it? If so I am speculating that maybe there is a delay due to BC Genetics waiting for that or maybe they were one of the 100 that were rejected in BC and waiting to reapply? Is that even possible? Just looking for reasons or answers as to the delay other than low share price. I know David bought some shares at .145 a month or two ago which is a good sign to me in the long run.
Bullboard Posts